Dusa Pharmaceuticals Reports Q4 EPS of $0.12

Dusa Pharmaceuticals DUSA reported its Q4 EPS at $0.12, versus the consensus of $0.04. DUSA reported its Q4 revenue at $12 million, versus the consensus of $10.28 million.

 

DUSA shares gained 7.02% to close at $3.20 yesterday.

 

Read more <a href="http://www.benzinga.com/markets/company-news">from Benzinga's Company news.</a>

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBiotechnologyEarningsHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!